Developing new methods to create important organic compounds
New Methods for Nitrogen and Oxygen Heterocycle Synthesis
['FUNDING_OTHER'] · STATE UNIVERSITY OF NEW YORK AT BUFFALO · NIH-11090434
This study is exploring new ways to make important small molecules that can help develop better medicines, using a special technique that reduces waste, with the goal of finding new treatments for different health conditions.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STATE UNIVERSITY OF NEW YORK AT BUFFALO (nih funded) |
| Locations | 1 site (AMHERST, UNITED STATES) |
| Trial ID | NIH-11090434 on ClinicalTrials.gov |
What this research studies
This research focuses on creating efficient methods for synthesizing small organic molecules that are crucial in pharmaceutical development. By using innovative copper-catalyzed reactions, the project aims to produce chiral compounds that are essential for drug discovery while minimizing waste. The approach emphasizes the synthesis of complex molecules that could lead to new bioactive natural products and pharmaceuticals, potentially improving treatment options for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be treated by new pharmaceuticals derived from these organic compounds.
Not a fit: Patients with conditions that are not addressed by the types of drugs produced from these organic compounds may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and sustainable methods for producing drugs, ultimately benefiting patients through improved therapies.
How similar studies have performed: Other research has shown success in developing efficient synthesis methods for organic compounds, indicating that this approach has potential for significant advancements.
Where this research is happening
AMHERST, UNITED STATES
- STATE UNIVERSITY OF NEW YORK AT BUFFALO — AMHERST, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEMLER, SHERRY R — STATE UNIVERSITY OF NEW YORK AT BUFFALO
- Study coordinator: CHEMLER, SHERRY R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Cardiovascular Diseases